Clinical trials recruiting for HCC - Hepatocellular Carcinoma
5
Recruiting trials
0
US states with sites
3
Countries
0%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| GV20-0251 | 2 |
| LXP1788 is administered intravenously via Port-A | 1 |
| TGI-5 | 1 |
Self-screener
Recruiting trials
- A Phase 1 Study of TGI-5 as Monotherapy and in Combination With Nivolumab in Subjects With Locally Advanced/Metastatic Solid Tumors
- A Phase I Study of LXP1788 Injection with Advanced Solid Tumors.
- A Study of GV20-0251 in Advanced or Refractory Solid Tumors
- PROtocol of Metabolic and Cryptogenic livEr Disease regisTry for intEgration of Omic Studies
- Study of GV20-0251 in Participants With Solid Tumor Malignancies
Related conditions
Trials recruiting for HCC - Hepatocellular Carcinoma often also study these conditions. Each links to its own recruiting-trial list.
Melanoma 487Solid Tumor Cancer 7Pancreatic cancer 870Non-small cell lung cancer 507Testicular Cancer 11Solid Tumour 5Solid Cancers 6Small cell lung cancer 87pMMR/MSS Adenocarcinoma of the Colon or Rectum 3Pancreatic Ductal Adenocarcinoma 64
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for HCC - Hepatocellular Carcinoma trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.